StockNews.com initiated coverage on shares of Mannatech (NASDAQ:MTEX – Free Report) in a report issued on Thursday. The brokerage issued a buy rating on the stock.
Mannatech Stock Performance
NASDAQ MTEX opened at $7.93 on Thursday. Mannatech has a 12-month low of $6.75 and a 12-month high of $16.49. The firm has a 50-day moving average price of $10.82 and a two-hundred day moving average price of $10.09. The company has a market capitalization of $15.07 million, a P/E ratio of -9.79 and a beta of 0.98. The company has a quick ratio of 0.74, a current ratio of 1.25 and a debt-to-equity ratio of 0.44.
Mannatech (NASDAQ:MTEX – Get Free Report) last issued its quarterly earnings results on Wednesday, March 26th. The company reported $1.20 earnings per share (EPS) for the quarter. The business had revenue of $29.01 million for the quarter. Mannatech had a negative return on equity of 15.62% and a negative net margin of 1.26%.
Mannatech Company Profile
Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.
Recommended Stories
- Five stocks we like better than Mannatech
- Insider Trading – What You Need to Know
- Shares of RH Down Nearly 40%: Where Investors Can Turn To Now
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Dividend Payout Ratio Calculator
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
Receive News & Ratings for Mannatech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mannatech and related companies with MarketBeat.com's FREE daily email newsletter.
